" class="no-js "lang="en-US"> VIDA Diagnostics Archives - Medtech Alert
Tuesday, May 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Strong Demand for Lung Intelligence Accelerates VIDA's Growth

VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, announced it has secured […]

VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)

VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more